News and Events:
-
Prospect Awarded New Key Patent
On October 2, 2012, the United States Patent and Trademark Office awarded Prospect Biosystems, Inc. a U.S. Patent (number 8,278,118) for a Method for the Fractionation and Separation of Particles by Step-wise Gradient Density Extraction. This patent is the first of a larger patent family and covers a method or system to identify a ratio of biomarkers from different fractions of a sample homogenate or lysate. This technology provides a powerful biology-based tool for the statistical evaluation of potential biomarkers. Additionally, oncologists now will have a unique opportunity for real-time molecular pathology in determination of clean margins during cancer surgery.
-
In 2011, Prospect signed distribution agreements for Australia. The company is currently negotiating distribution agreements for Japan and Europe.
-
In 2010, Prospect signed distribution agreements for Singapore, Taiwan, South Korea, and China.
Prospect Biosystems, Inc. engages in the development, manufacturing, and marketing of instrumentation, reagents, consumables, and assays for bioanalytical research and molecular pathology. Prospect’s proprietary Edge™ technology provides a powerful tool to enhance and accelerate life sciences research, pharmaceutical product development, clinical and molecular diagnostics and pathology.
Edge™ platform is a breakthrough bioanalytical fractionation and separation technology that allows scientists, researchers, medical experts, including physicians and surgeons, involved in:
- Biomarker Discovery to rapidly characterize differences between diseased and healthy tissue
- Clinical Diagnostics to easily identify and evaluate predictive, diagnostic and prognostic disease biomarkers
- Clinical Trials to accelerate and improve outcome prediction through use of surrogate biomarkers
- Molecular Pathology to facilitate outcome prediction through use of tissue biomarkers
- Analytical Proteomics to significantly enrich low-abundance proteins from their crude cell or tissue extracts
Prospect ... “Outlook for future success”